FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...

Novartis got a reprieve last week when the U.S. Patent and Trademark Office upheld a patent on its multiple sclerosis blockbuster Gilenya. Now, the Swiss pharma intends to use that win in court ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

Under a new patent settlement with multiple generics makers, Eli Lilly’s storied erectile dysfunction med Cialis will keep exclusive protections a little while longer. Cialis has generated more than ...

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls. Objectives: ...

Generics get treated like the “off-brand cereal” of medicine, but that’s not really how it works. In the U.S., generics have ...

The Food and Drug Administration approved the first generic for Afinitor, which can provide a safe, effective, lower cost alternative to the brand-name drug it references. The Food and Drug ...

Let’s face it, non-generic prescription drugs can be expensive. Generic drugs are an alternative for those looking to save some money. But is there a difference between the brand name and the cheaper ...

Credit: Getty Images. Lisdexamfetamine dimesylate capsules and chewable tablets are indicated for ADHD in patients aged 6 years and older, and for moderate to severe binge-eating disorder in adults.

The health care sector, the third-largest sector weight in the S&P 500, is bouncing back in an impressive fashion this year after posting its first annual loss last year since 2008. While diversified ...